Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
We are sorry, but we are unable to retrieve the events at the moment due to a connection issue. Please try to refresh the page or check back later.